CN107635534B - Oral care compositions - Google Patents

Oral care compositions Download PDF

Info

Publication number
CN107635534B
CN107635534B CN201680027837.2A CN201680027837A CN107635534B CN 107635534 B CN107635534 B CN 107635534B CN 201680027837 A CN201680027837 A CN 201680027837A CN 107635534 B CN107635534 B CN 107635534B
Authority
CN
China
Prior art keywords
calcium
source
oral care
silicate
care composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680027837.2A
Other languages
Chinese (zh)
Other versions
CN107635534A (en
Inventor
李小科
王进防
张美丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever IP Holdings BV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of CN107635534A publication Critical patent/CN107635534A/en
Application granted granted Critical
Publication of CN107635534B publication Critical patent/CN107635534B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/884Sequential application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is a dual phase oral care composition comprising a first phase comprising a calcium source and a second phase comprising a water-soluble silicate source, wherein the calcium source and the silicate source are physically separated prior to use of the composition.

Description

Oral care compositions
Technical Field
The present invention relates to dual phase oral care compositions such as toothpastes, gums (gum), and the like. In particular, the present invention relates to a biphasic oral care composition which causes remineralization and/or whitening of teeth by delivering a calcium source and a silicate source to the teeth of an individual, for example, during brushing. The invention also relates to the use of such compositions for remineralising and/or whitening teeth of an individual.
Background
The enamel layer of a tooth is naturally opaque white or slightly off-white. However, the enamel layer may stain or discolor. The enamel layer of a tooth is composed of hydroxyapatite mineral crystals forming a somewhat porous surface. It is believed that this porous nature of the enamel layer enables staining agents and coloring substances to penetrate the enamel and discolor the tooth.
Many products we consume have a negative impact on our teeth and mouth. Acidic drinks and confections can cause tooth erosion, for example, by eroding the enamel, which is the outer coating that protects the teeth. In addition, tobacco-based products, as well as beverages like coffee and tea, can stain teeth or reduce the whiteness of teeth. These staining and coloring substances are often able to penetrate the enamel layer. This problem occurs gradually over the years, but can cause significant discoloration of the enamel.
In addition to our consumption, the natural balance between tooth hydroxyapatite being dissolved from the enamel and hydroxyapatite being formed on or in the tooth from substances naturally present in saliva is also constantly migrating. This migration can produce unattractive teeth with cariogenic conditions. Various products are currently used to address the problems of dental caries and/or tooth whitening. Such products often contain peroxides, abrasives, or both. These types of products are often undesirable because they do not contribute to tooth remineralization and can cause damage to teeth and gums if used in excess. Products containing a calcium source have been developed in an attempt to enhance remineralization of teeth.
The present inventors have now developed a dual phase oral care composition which delivers a calcium source to the surface of the teeth, simultaneously or sequentially with the application of a water soluble silicate source, and the formation of calcium silicate hydrate in situ. This in situ formed calcium silicate hydrate will adhere to enamel, dentin, or both and is a precursor for hydroxyapatite formation. The calcium source and silicate source are physically separated prior to use of the oral care composition and are delivered from separate phases to prevent premature reaction between the two sources. It has been surprisingly found that such in situ formed calcium silicate hydrate appears to be much more active for tooth remineralisation than pre-formed calcium silicate hydrate. Furthermore, by using in situ formed calcium silicate hydrate instead of pre-formed calcium silicate hydrate, it will help to simplify the manufacturing process and reduce costs. It has further been found that calcium silicate hydrate formed in situ can act as a deposition aid and enhance the deposition of particulate tooth whitening agents onto the surface of the teeth to provide tooth whitening benefits.
Additional information
WO 2008/068149 a (unilever) discloses an oral care product comprising a first composition comprising an insoluble calcium salt which is not a calcium phosphate salt; a second independent composition comprising a source of phosphate ions; and means for delivering each composition to the tooth surface (means). A preferred insoluble calcium salt is calcium silicate.
WO 2012/031785 a (unilever) discloses composite particle actives suitable for use in oral care compositions. The composite particle active has a core and a coating, wherein the coating interacts with phosphate ions to produce calcium and phosphate reaction products suitable for adhering to tooth enamel and/or dentin in order to improve tooth characteristics.
WO 2012/031786 a (unilever) discloses an oral care composition with a composite particle active as described in WO 2012/031785 a (unilever).
None of the above references describe a dual phase oral care composition comprising a first phase comprising a calcium source and a second phase comprising a water soluble silicate source, in particular the calcium source and silicate source are delivered simultaneously or sequentially to the tooth surface to form calcium silicate hydrate in situ which adheres to enamel, dentin or both and is a precursor for hydroxyapatite formation.
Testing and defining
Two-phase
For the purposes of the present invention, "biphasic" means a composition having two separate phases that are physically separated.
Dentifrice formulation
For the purposes of the present invention, "dentifrice" means a paste, powder, liquid, gel or other preparation used to clean teeth or other surfaces in the oral cavity.
Toothpaste tube
For the purposes of the present invention, "toothpaste" means a paste or gel dentifrice used with a toothbrush. Particularly preferred are toothpastes suitable for cleaning teeth by brushing for about two minutes.
Gargle
For the purposes of the present invention, "mouthwash" means a liquid dentifrice used to rinse the oral cavity. Mouthwashes suitable for rinsing the oral cavity by rinsing and/or gargling for about half a minute before expectoration are particularly preferred.
Particle size
As used herein, "particle size" refers to the particle diameter, unless otherwise specified. The diameter means the largest measurable distance or major dimension on the particle without creating a well-defined sphere. The particle size can be measured, for example, by Dynamic Light Scattering (DLS).
Composite particles
As used herein, "composite particle" refers to a particle comprising a core of a first component and a coating of a second component, wherein the core and coating are comprised of different materials.
Refractive index:
the refractive index is the refractive index quoted at a temperature of 25 ℃ and a wavelength of 589 nm.
Solubility in water
As used herein, "soluble" and "insoluble" refer to the solubility of a source (e.g., such as a calcium salt) in water at 25 ℃ and atmospheric pressure. By "soluble" is meant that the source is dissolved in water to give a solution having a concentration of at least 0.1 moles/liter. By "insoluble" is meant that the source is dissolved in water to give a solution having a concentration of less than 0.001 moles/liter. Thus, "sparingly soluble" is defined to mean that the source is dissolved in water to give a solution at a concentration higher than 0.001 moles/liter and less than 0.1 moles/liter.
Is substantially free of
As used herein, "substantially free" means containing less than 1.5 wt%, preferably less than 1.0 wt%, more preferably less than 0.75 wt%, still more preferably less than 0.5 wt%, even more preferably less than 0.1 wt%, most preferably 0.0 to 0.01 wt%, based on the total weight of the oral care composition, including all ranges subsumed therein.
Aqueous composition
As used herein, "aqueous composition" means that the composition comprises more than 1.5%, preferably more than 5%, more preferably more than 10% and most preferably 20-90% water by weight of the composition.
Viscosity of the oil
The viscosity of the toothpaste is the value obtained with a Brookfield viscometer number 4 spindle and at 5rpm at room temperature (25 ℃). Unless otherwise stated, values are quoted in centipoise (cP ═ mpa.s).
In situ
As used herein, "in situ" means during and/or after application of the oral care composition to the oral cavity.
Remineralisation of
As used herein, "remineralization" means the generation of calcium phosphate (including layers on teeth from 10nm to 20 microns, preferably 75nm to 10 microns, and most preferably 150nm to 5 microns thick, including all ranges subsumed therein) in situ on teeth (i.e., in the oral cavity) to reduce tooth sensitivity, the likelihood of caries, regenerate enamel, and/or improve the appearance of teeth by whitening through the generation of this new calcium phosphate.
Deposition aid
Deposition aid as used herein means a material that aids in the deposition of particulate tooth whitening agent from the continuous phase of the oral care composition onto the tooth surface during use of the composition.
Miscellaneous items
Except in the examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use may optionally be understood as modified by the word "about".
All amounts are by weight of the final oral care composition, unless otherwise specified.
It should be noted that when any range of values is specified, any particular upper limit value can be associated with any particular lower limit value.
For the avoidance of doubt, the word "comprising" is intended to mean "including", but not necessarily "consisting of … …" or "consisting of … …". In other words, the listed steps or options need not be exhaustive.
The disclosure of the invention appearing herein is to be considered to cover all embodiments found in the claims multiply dependent on each other, irrespective of the fact that claims may be found without multiple dependencies or redundancies.
When a feature is disclosed with respect to one particular aspect of the invention (e.g., a composition of the invention), the disclosure is also deemed applicable, mutatis mutandis, to any other aspect of the invention (e.g., a method of the invention).
Disclosure of Invention
In a first aspect, the present invention relates to a dual phase oral care composition comprising:
a) a first phase comprising a calcium source;
b) a second phase comprising a water-soluble silicate source; and is
Wherein the calcium source and the silicate source are physically separated prior to use of the composition.
In a second aspect, the present invention relates to a packaged oral care product comprising the oral care composition of the first aspect of the invention.
In a third aspect, the present invention relates to a method of remineralizing and/or whitening the teeth of an individual comprising the step of applying the oral care composition of any embodiment of the first aspect to at least one surface of the teeth of the individual.
All other aspects of the invention will become more readily apparent after consideration of the following detailed description and examples.
Detailed Description
It has now been found that calcium silicate hydrate, which adheres to enamel, dentin, or both, and is a precursor for hydroxyapatite formation, can be formed in situ by a calcium source and a silicate source delivered to the tooth surface simultaneously or sequentially. It has been surprisingly found that such in situ formed calcium silicate hydrate appears to be much more active for tooth remineralisation than pre-formed calcium silicate hydrate. Furthermore, by using in situ formed calcium silicate hydrate instead of pre-formed calcium silicate hydrate, it helps to simplify the manufacturing process and reduce costs. In addition, it has further been found that calcium silicate hydrate formed in situ can act as a deposition aid and enhance the deposition of particulate tooth whitening agents onto the surface of the teeth to provide tooth whitening benefits.
The calcium source suitable for use in the present invention is limited only to the extent that the calcium source can be used in the mouth.
Illustrative, but non-limiting, examples of the types of calcium sources that may be used in the present invention include, for example, calcium hydroxide, calcium gluconate, calcium oxide, calcium lactate, calcium sulfate, calcium carboxymethylcellulose, calcium alginate, calcium salts of citric acid, calcium chloride, calcium nitrate, calcium acetate, mixtures thereof, and the like. In a preferred embodiment, the calcium source is calcium hydroxide, calcium nitrate, calcium sulfate or mixtures thereof.
In a particularly preferred embodiment, the calcium source is water soluble and/or sparingly water soluble.
Generally, the calcium source is present in an amount of from 0.1 to 50%, more preferably from 0.2 to 30%, most preferably from 1 to 20%, based on the total weight of the oral care composition and including all ranges subsumed therein.
Preferably, the first phase of the oral care composition is substantially free of silicate ions.
Silicate sources suitable for use in the present invention are limited only to the extent that the silicate source can be used in the mouth. Silicates as used herein are oxides containing silicon oxyanions (silicon oxyanions). Preferably, the silicate comprises or is of anionic SiO4 4-Of (4) an orthosilicate.
In a preferred embodiment, the silicate source is water soluble. Illustrative, but non-limiting examples of the types of silicate sources suitable for use in the present invention include, for example, sodium silicate, potassium silicate, tetraethyl orthosilicate, tetraethyl silicate, mixtures thereof, and the like. In a preferred embodiment, the silicate source is sodium silicate.
Typically, the silicate source is present in an amount of from 0.5 to 50%, more preferably from 2 to 40%, and most preferably from 5 to 35%, based on the total weight of the oral care composition and including all ranges subsumed therein.
Preferably, the second phase of the oral care composition is substantially free of calcium ions.
The oral care composition preferably comprises a calcium source and a silicate source in a molar ratio (Ca: Si) of less than 1:1, more preferably less than 1:1.2, still more preferably from 1:1.5 to 1:4 and most preferably from 1:1.7 to 1: 3.
The oral care compositions of the present invention may further comprise a particulate whitening agent, such as high refractive index particles. The only limitation with respect to the high refractive index particles that can be used in the present invention is that they should be suitable for use in the mouth.
It is believed that the deposition of the high refractive index particles onto the tooth surface is aided by the dual phase composition. Calcium silicate hydrate is formed in situ by delivering calcium and silicate ions from separate phases, which results in the formation of hydroxyapatite that contributes to the deposition of high refractive particles.
In order to provide an excellent whitening effect, the particles of the present invention preferably have a high refractive index of at least 1.9, more preferably at least 2.0, even more preferably at least 2.2, even still more preferably at least 2.4 and most preferably at least 2.5. The maximum refractive index of the high refractive index particles is not particularly limited, but is preferably up to 4.0.
Typically, the high refractive index particles comprise a material suitable for physically and immediately improving the properties of teeth and in particular whitening teeth. Particularly suitable materials are metal salts, preferably salts wherein the metal is selected from zinc (Zn), titanium (Ti), zirconium (Zr) or combinations thereof. Preferably, the metal salt is (or at least comprises) a metal oxide such as titanium dioxide (TiO)2) Zinc oxide (ZnO), zirconium dioxide (ZrO)2) Or a combination thereof. In addition, the high refractive index particles may further include a non-metal oxide, such as silicon monoxide (SiO).
In a preferred embodiment, the high refractive index particles comprise a metal oxide, a non-metal oxide, or a combination thereof in an amount of at least 50%, more preferably at least 70%, still more preferably 80-100% and most preferably 85-95% by weight of the particle. In a particularly preferred embodiment, the high refractive index particles are at least 50 weight percent titanium dioxide, most preferably 60 to 100 weight percent titanium dioxide, based on the total weight of the high refractive index particles and including all ranges subsumed therein. In another particularly preferred embodiment, the high refractive index particles are sparingly soluble or insoluble in water, but most preferably are insoluble in water.
In a preferred embodiment, the high refractive index particles are composite particles. The refractive index of a composite particle comprising more than one material may be calculated using effective medium theory and based on the refractive indices and volume fractions of the components, as described in, for example, WO 2009/023353.
The composite particle includes a first component core and a second component coating. Typically, the core of the composite particle comprises a material suitable for physically and immediately improving the characteristics of the tooth and in particular whitening the tooth. Particularly suitable materials are metal salts, and preferred are salts wherein the metal is selected from zinc (Zn), titanium (Ti), zirconium (Zr), or combinations thereof. Preferably, the metal salt is (or at least comprises) a metal oxide, such as titanium dioxide (TiO)2) Zinc oxide (ZnO), zirconium dioxide (ZrO)2) Or a combination thereof. In addition, the core of the composite particle may further comprise a non-metal oxide, such as silicon monoxide (SiO).
The core of the composite particle typically constitutes from 3 to 98 wt%, preferably from 6 to 65 wt%, most preferably from 10 to 55 wt% of the composite particle, based on the total weight of the composite particle and including all ranges subsumed therein. In a preferred embodiment, the core comprises a metal oxide, a non-metal oxide or a combination thereof in an amount of at least 50%, and more preferably at least 70%, still more preferably 80-100% and most preferably 85-95% by weight of the core. In a particularly preferred embodiment, the core is at least 50 wt% titanium dioxide, most preferably 60 to 100 wt% titanium dioxide, based on the total weight of the first component core.
The second component coating comprises a material suitable for adhering to enamel, dentin, or both. Typically, the coating material comprises elemental calcium and optionally other metals such as potassium, sodium, aluminum, magnesium and mixtures thereof, wherein such optional metals are provided as, for example, sulfates, lactates, oxides, carbonates or silicates. Optionally, the coating material may be alumina or silica. In a preferred embodiment, the coating material is adapted to provide long-term biological or chemical modification of the teeth (e.g., resulting in the formation of hydroxyapatite). Preferably, the coating used comprises at least 50 wt% of elemental calcium, most preferably at least 65 wt% of elemental calcium, based on the total weight of the metals in the coating. In a particularly preferred embodiment, the metal in the coating is 80 to 100 weight percent elemental calcium, based on the total weight of the metals in the second component coating and including all of the above ranges subsumed therein. In another particularly preferred embodiment, the core and coating are sparingly soluble or insoluble in water, but most preferably insoluble in water.
In one particularly desirable embodiment, the second component coating can comprise, for example, calcium phosphate, calcium gluconate, calcium oxide, calcium lactate, calcium carbonate, calcium hydroxide, calcium sulfate, calcium carboxymethylcellulose, calcium alginate, calcium salts of citric acid, calcium silicate, mixtures thereof, and the like. In another desirable embodiment, the calcium source in the coating comprises calcium silicate.
In yet another preferred embodiment, the coating may comprise elemental calcium derived from insoluble calcium silicate and as a composite calcium oxide-silica (CaO-SiO)2) Such as described in international patent applications published as WO 2008/015117 and WO 2008/068248.
When a calcium silicate composite is used as the coating, the ratio of calcium to silicon (Ca: Si) may be 1:10 to 3: 1. The Ca to Si ratio is preferably 1:5 to 2:1, and more preferably 1:3 to 2:1, most preferably about 1:2 to 2: 1. The calcium silicate may comprise monocalcium silicate, dicalcium silicate or tricalcium silicate, wherein the ratio of calcium to silicon (Ca: Si) is understood to be an atomic ratio.
Typically, at least 30% of the outer surface area of the first component core is coated with the second component coating, preferably at least 50% of the core is coated with the coating, most preferably 70-100% of the outer surface area of the first component core is coated with the second component coating.
In a particularly preferred embodiment, the high refractive index particles are titanium dioxide coated with calcium silicate.
The high refractive index particles according to the present invention may have different sizes and shapes. The particles may be in the form of spheres, platelets or irregular shapes. The high refractive index particles often have a diameter of 10nm to less than 50 microns, and preferably 75nm to less than 10 microns. In a particularly preferred embodiment, the particles have a diameter of 100nm to 5 microns, including all ranges subsumed therein. For the composite particles, in preferred embodiments, at least 40% and preferably at least 60% and most preferably 75 to 99.5% of the diameter of the composite particle is the core, including all ranges subsumed therein.
Generally, the oral care compositions of the present invention comprise from 0.25 to 60 weight% and preferably from 0.5 to 40 weight% and most preferably from 1 to 30 weight% of the high refractive index particles, based on the total weight of the oral care composition and including all ranges subsumed therein.
It was found that the oral care compositions of the present invention are capable of remineralizing teeth in situ without the inclusion of a phosphate source in the composition itself. Without wishing to be bound by theory, the inventors believe that this may be because the Si-OH groups may have an affinity for Ca ions in the teeth and the calcium silicate hydrate formed in situ reacts with phosphate ions in saliva, leading to the formation of hydroxyapatite.
Thus, in one embodiment, the composition may be substantially free of a phosphate source.
Preferably, the dual phase oral care composition comprises a phosphate source.
The phosphate source useful in the present invention is limited only to the extent that the phosphate source can be used in compositions suitable for oral use. Illustrative examples of the types of phosphate sources suitable for use in the present invention include trisodium phosphate, monosodium dihydrogen phosphate, disodium hydrogen phosphate, sodium pyrophosphate, tetrasodium pyrophosphate, sodium hexametaphosphate, tripotassium phosphate, monopotassium phosphate, dipotassium hydrogen phosphate, mixtures thereof, and the like. The phosphate source is preferably a water soluble source.
When used, the phosphate source typically comprises from 0.5 to 22 weight%, and preferably from 2 to 18 weight%, and most preferably from 4 to 16 weight%, of the oral care composition, based on the total weight of the oral care composition and including all ranges subsumed therein. In a preferred embodiment, the phosphate sources used are trisodium phosphate and monosodium phosphate, the weight ratio of trisodium phosphate to monosodium phosphate being from 1:4 to 4:1, preferably from 1:3 to 3:1 and most preferably from 1:2 to 2:1, including all ratios contained therein.
The compositions of the present invention are oral care compositions and typically comprise a physiologically acceptable carrier. The carrier preferably comprises at least a surfactant, a thickener, a humectant, or a combination thereof.
Preferably, the oral care composition comprises a surfactant. Preferably, the composition comprises at least 0.01%, more preferably at least 0.1% and most preferably from 0.5 to 7% by weight of the composition of surfactant. Suitable surfactants include anionic surfactants, such as C8To C18Alkyl sulfates (e.g. sodium lauryl sulfate), C8To C18Alkyl sulfosuccinates (e.g. dioctyl sodium sulfosuccinate), C8To C18Alkyl sulfoacetates (e.g. sodium lauryl sulfoacetate), C8To C18Alkyl sarcosinates (e.g. sodium lauryl sarcosinate), C8To C18Alkyl phosphates (which may optionally contain up to 10 ethylene oxide and/or propylene oxide units) and sodium, magnesium, ammonium or ethanolamine salts of sulfated monoglycerides. Other suitable surfactants include nonionic surfactants such as optionally present polyethoxylated fatty acid sorbitan esters, ethoxylated fatty acids, esters of polyethylene glycol, ethoxylates of fatty acid monoglycerides and fatty acid diglycerides, and ethylene oxide/propylene oxide block polymers. Other suitable surfactants include amphoteric surfactants such as betaines or sulfobetaines. Mixtures of any of the above materials may also be used. More preferably, the surfactant comprises or is an anionic surfactant. Preferred anionic surfactants areSodium lauryl sulfate and/or sodium dodecylbenzenesulfonate. Most preferably, the surfactant is sodium lauryl sulfate.
Thickeners may also be used in the present invention and are limited only to the extent that they can be added to compositions suitable for use in the mouth. Illustrative examples of the types of thickeners that may be used in the present invention include sodium carboxymethylcellulose (SCMC), hydroxyethylcellulose, methylcellulose, ethylcellulose, tragacanth gum, acacia gum, karaya gum, sodium alginate, carrageenan, guar gum, xanthan gum, Irish moss, starch, modified starch, silica-based thickeners including silica aerogel, magnesium aluminum silicate (e.g., Veegum), Carbomer (cross-linked acrylate), and mixtures thereof.
In general, xanthan gum and/or sodium carboxymethylcellulose and/or carbomer are preferred. When carbomers are employed, it is desirable to have a weight average molecular weight of at least 700,000, preferably at least 1,200,000, and most preferably at least about 2,500,000. Mixtures of carbomers may also be used in the present invention.
In a particularly preferred embodiment, the carbomer is Synthalen PNC, Synthalen KP or a mixture thereof. It has been described as a high molecular weight and crosslinked polyacrylic acid and is identified as CAS number 9063-87-0. These types of materials are commercially available from suppliers such as Sigma.
In another particularly preferred embodiment, the sodium carboxymethylcellulose (SCMC) used is SCMC 9H. It has been described as the sodium salt of a cellulose derivative having a carboxymethyl group bound to the hydroxyl groups of the glucopyranose backbone monomer and is identified by CAS number 9004-32-4. Available from suppliers such as Alfa Chem.
In another particularly preferred embodiment, the thickening agent is xanthan gum.
Thickeners typically comprise from 0.01 to about 10 weight%, more preferably from 0.1 to 9 weight%, most preferably from 1.5 to 8 weight% of the oral care composition based on the total weight of the oral care composition and including all ranges subsumed therein.
When the oral care composition of the present invention is a toothpaste or gel, it typically has a viscosity of from about 30,000 to 180,000 centipoise, and preferably from 60,000 to 170,000 centipoise, and most preferably from 65,000 to 165,000 centipoise.
Suitable humectants are preferred for use in the oral care compositions of the present invention and they include, for example, glycerin, sorbitol, propylene glycol, dipropylene glycol, diglycerin, triacetin, mineral oil, polyethylene glycol (preferably PEG-400), alkane diols such as butylene glycol and hexylene glycol, ethanol, pentylene glycol, or mixtures thereof. Glycerin, polyethylene glycol, sorbitol or mixtures thereof are preferred humectants.
The humectant may be present in the range of 10 to 90% by weight of the oral care composition. More preferably, the carrier humectant constitutes from 25 to 80 weight percent, most preferably from 45 to 70 weight percent of the composition, based on the total weight of the composition and including all ranges subsumed therein.
The oral care compositions of the present invention may contain various other ingredients commonly used in the art for enhancing physical properties and performance. These ingredients include antimicrobial agents, anti-inflammatory agents, anti-caries agents, plaque buffers (plaque buffers), fluoride sources, vitamins, botanical extracts, desensitizing agents, anticalculus agents, biomolecules, flavoring agents, proteinaceous materials, preservatives, opacifiers, colorants, pH adjusters, sweeteners, particulate abrasive materials, polymeric compounds, buffers, and salts to buffer the pH and ionic strength of the composition, and mixtures thereof. Such ingredients typically and collectively comprise less than 20% by weight of the composition, and preferably from 0.0 to 15% by weight, and most preferably from 0.01% to 12% by weight of the composition, including all ranges subsumed therein.
The oral care compositions of the present invention are useful in methods of remineralizing and/or whitening the teeth of an individual comprising applying the composition to at least one surface of the teeth of the individual. The oral care compositions of the invention may additionally or alternatively be used as a medicament and/or in the manufacture of a medicament to provide oral care benefits as described herein, such as for remineralization of an individual's teeth. Alternatively and preferably, the use is non-therapeutic.
The calcium source and the silicate source are kept physically separated from each other by having them in separate phases. The delivery of the two separate phases to the tooth may be simultaneous or sequential. In a preferred embodiment, the phases are delivered simultaneously.
Typically, the biphasic composition is delivered through a dual tube allowing co-extrusion of the two phases, the dual tube having a first compartment for a first phase comprising the calcium source and a second compartment for a second phase comprising the silicate source.
In a preferred embodiment, one of the compartments of such a double tube surrounds the other. In such embodiments, one phase exists as a shell (skin) surrounding another phase in the core. In a particularly preferred embodiment, the phase as core comprises a source of calcium and the shell phase comprises a source of silicate.
In another preferred embodiment, such a double tube has two compartments side by side within the same tube. In such embodiments, the two phases are extruded from the tube as one, such extrusion being referred to as "contact extrusion". A pump head may be used in this double tube for extruding the two phases integrally from the tube.
The dual phase oral care composition may be a gel composition comprising two separate gel phases, the first phase comprising a calcium source and the second phase comprising a silicate source. The delivery means may involve a cotton swab or tray (tray) onto which the calcium source and silicate source are applied, which is then placed in contact with the teeth.
The dual phase oral composition may be effective even when used in an individual's routine of daily oral hygiene. For example, the composition may be brushed onto the teeth of the individual and/or rinsed around the interior of their mouth. The composition may be contacted with the teeth, for example, for a period of 1 second to 20 hours. More preferably from 10 seconds to 10 hours, still more preferably from 30 seconds to 1 hour, most preferably from 30 seconds to 5 minutes. The composition may be administered daily, for example, once, twice or three times daily for an individual. In another embodiment, when the biphasic composition is a gel composition, the two phases of the composition are mixed during application. The mixed phases are typically left (left) on the teeth for 3 minutes to 10 hours, more preferably 3 minutes to 8 hours. Administration may be daily.
The following examples are provided to facilitate an understanding of the invention. The described embodiments are not provided to limit the scope of the claims.
Examples
Example 1
This example demonstrates the improved deposition of in situ formed Calcium Silicate Hydrate (CSH) on the tooth surface compared to pre-formed CSH. All ingredients are expressed as weight percent of each phase of the total formulation and are expressed as levels of active ingredient.
TABLE 1
Figure BDA0001466653310000121
TABLE 2
Figure BDA0001466653310000131
Preparation of calcium silicate hydrate powder
A mixture of calcium hydroxide and sodium silicate in deionized water was used to prepare the preformed CSH. The mixture was formed at an initial Ca: Si ratio of 1: 2. The mixture was stirred continuously at room temperature (25 ℃). The pH of the reaction mixture was adjusted to about 11 and maintained at about 11 using hydrochloric acid. After stirring for 5 hours, the reaction mixture was filtered and the filter cake was washed three times with water and then filtered again. The filter cake was dried in an oven at 80 ℃ for 12 hours to obtain the final CSH powder.
Method
For samples 1 to 4 and samples 6 to 9, the calcium phase and silicate phase were prepared at a molar ratio of 1:2, which is the same molar ratio of Ca/Si as the preformed CSH.
To evaluate deposition on the enamel surface, for samples 1 to 4, the silicate phase was first added to the enamel surface, and then brushing was started, at which time the calcium phase was also added. For samples 6 and 9, the silicate and calcium phases were first mixed and added to the enamel surface, then brushing was started with the addition of 10mL of water. For sample 5, a slurry was prepared by mixing 1g of preformed CSH with 10mL of water and poured onto the enamel surface.
Bovine enamel blocks were treated with different samples by brushing according to the same protocol. And brushing the enamel block under a tooth brushing machine provided with a toothbrush. The brushing load was 170g +/-5g and automatic brushing was operated at 150 rpm. After 3 minutes of brushing, the enamel blocks were rinsed twice with distilled water and soaked in Simulated Oral Fluid (SOF) under shaking water bath conditions at 37 ℃ and 60.0 rpm. After about 5 hours of soaking, the enamel block was brushed with the slurry through the machine using the same procedure as in the first step. These steps are considered to be the entire processing cycle. The enamel blocks were treated 1 and 3 times.
Simulated oral fluids were prepared by combining the ingredients in table 3:
TABLE 3
Composition (I) Amount per g
NaCl 16.07
NaHCO3 0.7
KCl 0.448
K2HPO4*3H2O 3.27
MgCl2*6H2O 0.622
1M HCl 40ml
CaCl2 0.1998
Na2SO4 0.1434
Buffer solution Adjusting the pH to 7.0
Water (W) Equilibrate to 2L
Results
After the one-time treatment and the three-time treatment, Scanning Electron Microscope (SEM) photographs of the surface of the enamel block were taken. It is apparent from the SEM photographs that samples 1 to 4 and samples 6 to 9 produced more uniform and denser deposits on the tooth surface than sample 5, which contained preformed CSH.
Analysis using EDX (energy dispersive X-ray spectroscopy) identified Si, Ca and P elements within the new layer, indicating that Calcium Silicate (CS) was deposited on the tooth surface and induced remineralization.
Example 2
This example demonstrates improved deposition of particles by using CSH formed in situ. All ingredients are expressed as weight percent of each phase of the total formulation and are expressed as levels of active ingredient.
TABLE 4
Figure BDA0001466653310000141
a. Calcium silicate coated titanium dioxide commercially available from KOBO Products
Method
For samples 10 and 11, the calcium phase and silicate phase were first mixed and added to the enamel surface, and then brushing was initiated upon addition of water.
For sample 12, a fresh slurry was prepared by mixing the sample with water at a ratio of 5g to 10mL of water and used immediately.
Bovine enamel blocks were treated with different samples by brushing according to the same protocol. And brushing the enamel block under a tooth brushing machine provided with a toothbrush. The brushing load was 170g +/-5g and automatic brushing was operated at 150 rpm. After 3 minutes of brushing, the enamel blocks were rinsed twice with distilled water and soaked in SOF for more than 5 hours at 37 ℃ and 60.0rpm in a shaking water bath. After about 5 hours of soaking, the enamel block was brushed with the slurry through the machine using the same procedure as in the first step. These steps are considered to be the entire processing cycle. The enamel blocks were treated 5 times. The enamel block was further brushed with water before taking the SEM photograph.
Results
After one and five treatments, SEM photographs of the surface of the enamel block were taken. For samples 10 and 11, the formation of a new layer is shown from the SEM photograph, and the particles or particle aggregates are uniformly embedded in the newly formed layer.
But for sample 12, SEM pictures only showed particles randomly attached to the enamel surface. Furthermore, most of the attached particles were easily brushed off for sample 12. But for samples 10 and 11 the photographs clearly show that the particles remain in the newly formed layer, indicating that CSH formed in situ contributes to particle deposition onto the enamel surface. Analysis using EDX further identified elements Ti, Ca and P within the new layer, indicating that particles were deposited on the tooth surface.
Example 3
This example shows a dual phase oral care composition consistent with the present invention.
TABLE 5
Figure BDA0001466653310000161

Claims (21)

1. A dual phase oral care composition comprising:
a) a first phase comprising a calcium source;
b) a second phase comprising a silicate source dissolved in water at 25 ℃ and atmospheric pressure to give a solution having a concentration of at least 0.1 moles/liter; and is
Wherein the calcium source and the silicate source are physically separated prior to use of the composition;
wherein the calcium source is calcium hydroxide, calcium gluconate, calcium oxide, calcium lactate, calcium sulfate, carboxymethylcellulose calcium, calcium alginate, calcium salt of citric acid, calcium chloride, calcium nitrate, calcium acetate or a mixture thereof; and
wherein the silicate source comprises sodium silicate, potassium silicate, tetraethyl orthosilicate, tetraethylsilicate, or a mixture thereof.
2. The oral care composition according to claim 1, wherein the calcium source reacts with the silicate source to generate calcium silicate hydrate in situ that adheres to enamel, dentin, or both and is a precursor for hydroxyapatite formation.
3. The oral care composition of claim 1 or 2, wherein the calcium source is calcium hydroxide, calcium nitrate, calcium sulfate, or a mixture thereof.
4. The oral care composition of claim 1 or 2, wherein the calcium source is present in an amount ranging from 1% to 20% by weight of the first phase.
5. The oral care composition of claim 1 or 2, wherein the silicate source is sodium silicate.
6. The oral care composition of claim 1 or 2, wherein the molar ratio of calcium source to silicate source is from 1:1.5 to 1: 4.
7. The oral care composition of claim 1 or 2, wherein the molar ratio of calcium source to silicate source is from 1:1.7 to 1: 3.
8. The oral care composition of claim 1 or 2, wherein the composition further comprises high refractive index particles having a range of 1.9 to 4.0.
9. The oral care composition of claim 1 or 2, wherein the composition further comprises high refractive index particles having a range of 2.5 to 4.0.
10. The oral care composition of claim 8, wherein the high refractive index particles are zinc oxide, titanium dioxide, zirconium dioxide, or mixtures thereof.
11. The oral care composition of claim 10, wherein the high refractive index particles are titanium dioxide.
12. The oral care composition of claim 8, wherein the high refractive index particles are composite particles comprising a first component core comprising a metal compound; and a second component coating comprising elemental calcium and optionally potassium, sodium, magnesium, aluminum, or mixtures thereof.
13. The oral care composition according to claim 12, wherein the metal is selected from zinc, titanium, zirconium, or mixtures thereof.
14. The oral care composition according to claim 12, wherein the high refractive index particles are titanium dioxide coated with calcium silicate.
15. The oral care composition of claim 1 or 2, wherein the composition further comprises a phosphate source comprising trisodium phosphate, monosodium dihydrogen phosphate, disodium hydrogen phosphate, sodium pyrophosphate, sodium hexametaphosphate, tripotassium phosphate, monopotassium phosphate, dipotassium hydrogen phosphate or mixtures thereof.
16. A non-therapeutic method for remineralising and/or whitening the teeth of an individual comprising the step of applying a composition according to any one of claims 1 to 15 to at least one surface of the teeth of the individual.
17. The method of claim 16, wherein the calcium source and the silicate source are applied simultaneously or sequentially from spatially separated phases.
18. The method of claim 17, wherein the calcium source and the silicate source are applied simultaneously from spatially separated phases.
19. An oral care kit comprising (a) a first phase comprising a calcium source and (b) a second phase comprising a silicate source and (c) instructions for use;
wherein the calcium source and the silicate source are physically separated prior to their use;
wherein the calcium source is calcium hydroxide, calcium gluconate, calcium oxide, calcium lactate, calcium sulfate, carboxymethylcellulose calcium, calcium alginate, calcium salt of citric acid, calcium chloride, calcium nitrate, calcium acetate or a mixture thereof; and
wherein the silicate source comprises sodium silicate, potassium silicate, tetraethyl orthosilicate, tetraethylsilicate, or a mixture thereof.
20. The oral care kit according to claim 19 wherein the instructions comprise the step of applying the first and second phases to the tooth surface of the individual sequentially or simultaneously.
21. The oral care kit according to claim 19 wherein the instructions comprise the step of applying the first and second phases simultaneously to the tooth surface of the individual.
CN201680027837.2A 2015-05-13 2016-04-18 Oral care compositions Active CN107635534B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2015078847 2015-05-13
CNPCT/CN2015/078847 2015-05-13
EP15173259.1 2015-06-23
EP15173259 2015-06-23
PCT/EP2016/058495 WO2016180601A1 (en) 2015-05-13 2016-04-18 Oral care composition

Publications (2)

Publication Number Publication Date
CN107635534A CN107635534A (en) 2018-01-26
CN107635534B true CN107635534B (en) 2021-07-13

Family

ID=55754311

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680027837.2A Active CN107635534B (en) 2015-05-13 2016-04-18 Oral care compositions

Country Status (3)

Country Link
CN (1) CN107635534B (en)
BR (1) BR112017021670B1 (en)
WO (1) WO2016180601A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3668478B1 (en) * 2017-08-18 2022-04-13 Unilever Global IP Limited Oral care composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641558A1 (en) * 1993-09-02 1995-03-08 Unilever N.V. Stabilized peroxide gels containing fluoride and a zinc compound
CN1202815A (en) * 1995-11-02 1998-12-23 科尔加特·帕尔莫利弗公司 Dual component dentifrice composition for fluoridating teeth
CN1377252A (en) * 1999-08-05 2002-10-30 布洛克医药公司 Composition for restoring defects in calcified tissues

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788951A (en) * 1997-04-08 1998-08-04 Colgate-Palmolive Company Dual component dentifrice composition for fluoridating teeth containing compatible silica abrasive
BR0114587A (en) * 2000-10-13 2003-08-26 Block Drug Co Anhydrous dentifrice formulations for the release of incompatible ingredients
WO2008017203A1 (en) 2006-08-01 2008-02-14 Unilever Plc Biomaterials, their preparation and use
BRPI0720183B1 (en) * 2006-12-05 2019-03-26 Unilever N.V. PRODUCT FOR ORAL TREATMENT, PRODUCT UNDERSTANDING A FIRST COMPOSITION AND USE OF A FIRST COMPOSITION.
GB2463198B (en) 2007-05-23 2013-05-22 Univ Carnegie Mellon Hybrid particle composite structures with reduced scattering
WO2011109919A1 (en) * 2010-03-09 2011-09-15 Unilever Plc Stable oral care compositions
EP2613850B1 (en) * 2010-09-10 2016-11-23 Unilever PLC Composite particle active and method for making the same
CN107582413A (en) 2010-09-10 2018-01-16 荷兰联合利华有限公司 It is beneficial to the oral care composition of tooth
EP2572698A1 (en) * 2011-09-21 2013-03-27 Septodont ou Septodont SAS ou Specialites Septodont Wear resistant dental composition
EA027211B1 (en) * 2012-10-12 2017-06-30 Юнилевер Н.В. Oral care composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0641558A1 (en) * 1993-09-02 1995-03-08 Unilever N.V. Stabilized peroxide gels containing fluoride and a zinc compound
CN1202815A (en) * 1995-11-02 1998-12-23 科尔加特·帕尔莫利弗公司 Dual component dentifrice composition for fluoridating teeth
CN1377252A (en) * 1999-08-05 2002-10-30 布洛克医药公司 Composition for restoring defects in calcified tissues

Also Published As

Publication number Publication date
BR112017021670B1 (en) 2021-06-01
BR112017021670A2 (en) 2018-07-10
CN107635534A (en) 2018-01-26
WO2016180601A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
EP3043868B1 (en) Oral care composition
CN107809997B (en) Oral care compositions
CN107624064B (en) Oral care compositions
EP3648731B1 (en) Oral care composition
CN109890350B (en) Oral care compositions
EP3294260B1 (en) Oral care composition
CN110062617B (en) Oral care compositions
CN109640928B (en) Oral care compositions
CN107635534B (en) Oral care compositions
CN108348787B (en) Oral care compositions
CN111093603B (en) Oral care compositions
CN109152935B (en) Oral care compositions
EP3294259B1 (en) Oral care composition
EP3614994B1 (en) Oral care composition
EA038664B1 (en) Oral care composition
EA039652B1 (en) Oral care composition
EA039810B1 (en) Oral care composition based on zinc oxide and calcium dihydrogen phosphate
EA039452B1 (en) Oral care composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210830

Address after: Rotterdam

Patentee after: Unilever Intellectual Property Holdings Ltd.

Address before: Rotterdam

Patentee before: Netherlands Unilever Co.,Ltd.

TR01 Transfer of patent right